Clinical Trials in Philadelphia

Showing 19021-19040 of 20,904 trials

CAFE Comparison of Atypicals in First Episode of Psychosis

NCT00034892

The purpose of this study is to compare the effectiveness, tolerability, and efficacy of the currently available atypical antipsychotic drugs olanzapine (2.5-20 mg/day), quetiapine (100-800 mg/day) and risperidone (0.5-4 mg/day) in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder who are experiencing their first psychotic episode.

SchizophreniaPsychotic DisordersMental Health+1 more

AstraZenecaStarted Mar 2002

Stanford, California, United States • Miami, Florida, United States • Atlanta, Georgia, United States +23 more locations

COMPLETEDPhase 3< 1 mile

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

NCT00083954

The purpose of this study is to determine the efficacy of quetiapine compared to placebo in the treatment for a major depressive episode in patients with bipolar disorder after receiving treatment for up to 8 weeks.

Bipolar Disorder

AstraZeneca530 participantsStarted Jun 2004

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Cerritos, California, United States +33 more locations

CAFE Comparison of Atypicals in First Episode of Psychosis

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

Find Trials by Condition in Philadelphia

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania

Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial

Iressa Expanded Access Program (EAP)

Seroquel in Bipolar Depression Versus SSRI

Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Emergency Bedside Ultrasound for Pediatric Soft Tissue Infections

Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)

Dysrhythmias During General Anesthesia in Children

GM1 Ganglioside Effects on Parkinson's Disease

An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome

Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

A Study Of CP-690,550 In Stable Kidney Transplant Patients

Study of Antidepressants in Parkinson's Disease

Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus

A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer

An Open Label Extension Study of STX209 in Subjects With Autism Spectrum Disorders